Covered recipient · General Payments record
DOUGLAS JACKSON
Allopathic & Osteopathic Physicians Radiology Radiation Oncology
General Payments · PY2024
$454.94
- Reported across 8 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $454.94 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $243.15 | 2 |
| Acerta Pharma LLC | $125.00 | 1 |
| Exact Sciences Corporation | $20.39 | 1 |
| Daiichi Sankyo Inc. | $18.97 | 1 |
| Novo Nordisk AS | $17.12 | 1 |
| SHIELD THERAPEUTICS INC | $16.73 | 1 |
| Esperion Therapeutics, Inc. | $13.58 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $454.94 | 8 |
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $125.00 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105861296 | CMS |
| Daiichi Sankyo Inc. | $18.97 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089436808 | CMS |
| Esperion Therapeutics, Inc. | $13.58 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129439812 | CMS |
| Exact Sciences Corporation | $20.39 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114715309 | CMS |
| GlaxoSmithKline, LLC. | $123.97 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116524718 | CMS |
| GlaxoSmithKline, LLC. | $119.18 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116562090 | CMS |
| Novo Nordisk Inc | $17.12 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096786626 | CMS |
| SHIELD THERAPEUTICS INC | $16.73 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150134521 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.